ITGAL and neoplasm: Activated eosinophils up-regulate adhesion molecules (i.e., CD11a, CD11b, ICAM-1) and Siglec-F to enhance their survival and adhesion to tumor cells, thereby leading to contact-dependent degranulation and tumor killing [194, 197].